(BHE) Benchmark Electronics - Ratings and Ratios
Circuit Board, Assembly, Test, Aerospace, Medical
BHE EPS (Earnings per Share)
BHE Revenue
Description: BHE Benchmark Electronics
Benchmark Electronics Inc (NYSE:BHE) is a US-based company operating in the Electronic Manufacturing Services (EMS) sub-industry. The EMS industry provides manufacturing services for electronic components and products, such as printed circuit boards, computer systems, and medical devices.
To evaluate BHEs performance, we need to examine key financial metrics. The companys Market Cap stands at $1.42 billion, indicating a relatively modest size compared to industry giants. The Price-to-Earnings (P/E) ratio of 38.08 suggests that investors are willing to pay a premium for BHEs earnings, potentially due to growth expectations. However, the Return on Equity (RoE) of 2.87% is relatively low, indicating that the company may not be generating sufficient profits from shareholder equity.
Key economic drivers for the EMS industry include global demand for electronic devices, technological advancements, and the trend towards outsourcing manufacturing. BHEs revenue is likely influenced by these factors, as well as its own operational efficiency and ability to attract new customers. To improve performance, BHE may focus on optimizing its manufacturing processes, investing in new technologies, and expanding its customer base.
Some relevant KPIs to monitor BHEs performance include revenue growth, gross margin, and operating cash flow. A rising revenue growth rate and stable gross margin would indicate a healthy business, while a strong operating cash flow would suggest that the company is generating sufficient liquidity to invest in growth initiatives or return value to shareholders.
BHE Stock Overview
| Market Cap in USD | 1,292m |
| Sub-Industry | Electronic Manufacturing Services |
| IPO / Inception | 1990-06-28 |
BHE Stock Ratings
| Growth Rating | 22.3% |
| Fundamental | 39.5% |
| Dividend Rating | 50.7% |
| Return 12m vs S&P 500 | -17.9% |
| Analyst Rating | 4.0 of 5 |
BHE Dividends
| Dividend Yield 12m | 1.62% |
| Yield on Cost 5y | 3.55% |
| Annual Growth 5y | 1.15% |
| Payout Consistency | 98.8% |
| Payout Ratio | 30.2% |
BHE Growth Ratios
| Growth Correlation 3m | -10.4% |
| Growth Correlation 12m | -58.2% |
| Growth Correlation 5y | 66.4% |
| CAGR 5y | 17.49% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.48 |
| CAGR/Mean DD 3y (Pain Ratio) | 1.30 |
| Sharpe Ratio 12m | -0.60 |
| Alpha | -18.93 |
| Beta | 1.064 |
| Volatility | 45.37% |
| Current Volume | 422.7k |
| Average Volume 20d | 182k |
| Stop Loss | 40.2 (-4.1%) |
| Signal | 0.42 |
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (38.4m TTM) > 0 and > 6% of Revenue (6% = 155.3m TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA -7.00pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 31.09% (prev 31.52%; Δ -0.43pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 113.6m > Net Income 38.4m (YES >=105%, WARN >=100%) |
| Net Debt (-155.9m) to EBITDA (140.4m) ratio: -1.11 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.36 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (36.4m) change vs 12m ago -0.19% (target <= -2.0% for YES) |
| Gross Margin 10.14% (prev 9.91%; Δ 0.23pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 123.7% (prev 127.7%; Δ -4.05pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.84 (EBITDA TTM 140.4m / Interest Expense TTM 24.4m) >= 6 (WARN >= 3) |
Altman Z'' 4.48
| (A) 0.40 = (Total Current Assets 1.40b - Total Current Liabilities 592.1m) / Total Assets 2.03b |
| (B) 0.28 = Retained Earnings (Balance) 577.2m / Total Assets 2.03b |
| (C) 0.04 = EBIT TTM 93.7m / Avg Total Assets 2.09b |
| (D) 0.62 = Book Value of Equity 573.7m / Total Liabilities 924.0m |
| Total Rating: 4.48 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 39.47
| 1. Piotroski 4.0pt = -1.0 |
| 2. FCF Yield 5.78% = 2.89 |
| 3. FCF Margin 3.03% = 0.76 |
| 4. Debt/Equity 0.30 = 2.46 |
| 5. Debt/Ebitda -1.11 = 2.50 |
| 6. ROIC - WACC (= -7.55)% = -9.43 |
| 7. RoE 3.47% = 0.29 |
| 8. Rev. Trend -94.42% = -7.08 |
| 9. EPS Trend -38.22% = -1.91 |
What is the price of BHE shares?
Over the past week, the price has changed by +16.54%, over one month by +7.17%, over three months by +5.59% and over the past year by -5.23%.
Is Benchmark Electronics a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BHE is around 41.67 USD . This means that BHE is currently overvalued and has a potential downside of -0.6%.
Is BHE a buy, sell or hold?
- Strong Buy: 1
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the BHE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 44.7 | 6.6% |
| Analysts Target Price | 44.7 | 6.6% |
| ValueRay Target Price | 46.2 | 10.3% |
Last update: 2025-10-12 02:01
BHE Fundamental Data Overview
P/E Trailing = 34.5865
P/S = 0.499
P/B = 1.251
P/EG = 1.91
Beta = 1.064
Revenue TTM = 2.59b USD
EBIT TTM = 93.7m USD
EBITDA TTM = 140.4m USD
Long Term Debt = 203.4m USD (from longTermDebt, last quarter)
Short Term Debt = 19.8m USD (from shortTermDebt, last quarter)
Debt = 328.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -155.9m USD (from netDebt column, last quarter)
Enterprise Value = 1.36b USD (1.29b + Debt 328.1m - CCE 264.6m)
Interest Coverage Ratio = 3.84 (Ebit TTM 93.7m / Interest Expense TTM 24.4m)
FCF Yield = 5.78% (FCF TTM 78.3m / Enterprise Value 1.36b)
FCF Margin = 3.03% (FCF TTM 78.3m / Revenue TTM 2.59b)
Net Margin = 1.48% (Net Income TTM 38.4m / Revenue TTM 2.59b)
Gross Margin = 10.14% ((Revenue TTM 2.59b - Cost of Revenue TTM 2.33b) / Revenue TTM)
Gross Margin QoQ = 10.08% (prev 10.00%)
Tobins Q-Ratio = 0.67 (Enterprise Value 1.36b / Total Assets 2.03b)
Interest Expense / Debt = 1.93% (Interest Expense 6.35m / Debt 328.1m)
Taxrate = 94.15% (15.6m / 16.6m)
NOPAT = 5.48m (EBIT 93.7m * (1 - 94.15%))
Current Ratio = 2.36 (Total Current Assets 1.40b / Total Current Liabilities 592.1m)
Debt / Equity = 0.30 (Debt 328.1m / totalStockholderEquity, last quarter 1.11b)
Debt / EBITDA = -1.11 (Net Debt -155.9m / EBITDA 140.4m)
Debt / FCF = -1.99 (Net Debt -155.9m / FCF TTM 78.3m)
Total Stockholder Equity = 1.11b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.89% (Net Income 38.4m / Total Assets 2.03b)
RoE = 3.47% (Net Income TTM 38.4m / Total Stockholder Equity 1.11b)
RoCE = 7.15% (EBIT 93.7m / Capital Employed (Equity 1.11b + L.T.Debt 203.4m))
RoIC = 0.40% (NOPAT 5.48m / Invested Capital 1.36b)
WACC = 7.95% (E(1.29b)/V(1.62b) * Re(9.94%) + D(328.1m)/V(1.62b) * Rd(1.93%) * (1-Tc(0.94)))
Discount Rate = 9.94% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.65%
[DCF Debug] Terminal Value 62.40% ; FCFE base≈140.5m ; Y1≈92.3m ; Y5≈42.2m
Fair Price DCF = 17.40 (DCF Value 624.8m / Shares Outstanding 35.9m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -38.22 | EPS CAGR: -59.13% | SUE: -4.0 | # QB: 0
Revenue Correlation: -94.42 | Revenue CAGR: -6.45% | SUE: 0.19 | # QB: 0
Additional Sources for BHE Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle